Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.
JFK Communications served as Valeant’s PR partner to launch the Acanya Scholarship Program among dermatologists, primary care physicians, pediatricians, patients (students) and parents nationwide.
Acanya is a once–daily topical gel that combines two active ingredients – the antibiotic clindamycin phosphate and the antibacterial/antiinflammatory agent benzoyl peroxide – to treat acne.
JFK provided the following core services:
- Media relations around the national launch of the Acanya Scholarship Program
- National and local market PR
- Social media support
- Message and core materials development
- KOL development
- Sales force communications
- Video content
- Issues management
